Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.04. | Is Ontrak stock a buy? | 9 | Cantech Letter | ||
17.04. | Earnings call: Ontrak reports growth and AI advancements in Q4 | 14 | Investing.com | ||
16.04. | Ontrak Inc reports results for the quarter ended in December - Earnings Summary | 7 | Reuters | ||
16.04. | Ontrak, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
16.04. | Ontrak Non-GAAP EPS of -$0.27 misses by $0.06, revenue of $3.5M misses by $0.54M | 6 | Seeking Alpha | ||
16.04. | Ontrak, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
15.04. | Ontrak Q4 2023 Earnings Preview | 8 | Seeking Alpha | ||
08.04. | Ontrak, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
02.04. | Ontrak, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 9 | SEC Filings | ||
28.03. | Ontrak, Inc. - 8-K, Current Report | 30 | SEC Filings | ||
21.03. | Ontrak Launches New Engagement System | 40 | Baystreet.ca | ||
19.03. | OTRK, Sarcos Technology and Robotics and APM among mid-day movers | 25 | Seeking Alpha | ||
19.03. | Why Is Ontrak (OTRK) Stock Up 105% Today? | 49 | InvestorPlace | ||
12.03. | Ontrak Health expands partnership with Sentara Health | 19 | Investing.com | ||
12.03. | Ontrak Health announces continuing expansion with Sentara Health | 7 | Seeking Alpha | ||
29.02. | Ontrak Health partners with Sentara Health Plans | 8 | Seeking Alpha | ||
28.11.23 | Ontrak, Inc. - 8-K, Current Report | 18 | SEC Filings | ||
20.11.23 | Ontrak, Inc. - 10-Q, Quarterly Report | 13 | SEC Filings | ||
20.11.23 | NSE - Ontrak, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 9 | SEC Filings | ||
17.11.23 | Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical | 747 | GlobeNewswire (Europe) | NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.'s... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 60,61 | +14,40 % | Procept GAAP EPS of -$0.51, revenue of $44.5M | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 21,430 | 0,00 % | Mobile-health Retreats on Opening New Pharmacy | ||
ATRICURE | 24,810 | +2,78 % | AtriCure Q1 2024 Earnings Preview | ||
GENEDX | 20,880 | +21,89 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
PROGYNY | 32,270 | -0,03 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
ADAPTHEALTH | 10,060 | +2,13 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
RXSIGHT | 56,73 | +8,93 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
CVRX | 10,120 | 0,00 % | Pre-market Movers: IMCC, CVRX, TGTX, ROOT, PLTN. | WOONSOCKET (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 09.00 A.M. ET).In the Green IM Cannabis Corp. (IMCC) is up over 36% at $0.86.
TG... ► Artikel lesen | |
MIMEDX | 7,300 | +18,70 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
AGILON HEALTH | 4,955 | 0,00 % | agilon health Reports Fourth Quarter 2023 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,000 | -2,17 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
AGILITI | 10,105 | 0,00 % | DigitalOcean to replace Agiliti in S&P SmallCap Index | ||
NANO-X IMAGING | 9,150 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
DOCGO | 3,390 | +0,30 % | Evaluating DocGo: Insights From 8 Financial Analysts | ||
CASTLE BIOSCIENCES | 22,060 | +4,55 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen |